Major International Study Reports the Impact of Genetics on Epigenetic Factors

Understanding what causes epigenetic variation could be a step closer thanks to a new atlas of genetic effects on epigenetic factors. The atlas, which has been established by an international consortium led by the University of Bristol, will enable scientists to learn more about the mechanisms underpinning gene regulation.

Epigenetic variation exists but it is unclear what causes this variation – is it genetic or is it the environment? It is also unclear how genetic differences that occur between individuals’ impact on our epigenomes.  The atlas of genetic effects on DNA methylation (DNAm), by the Genetics of DNA Methylation Consortium (GoDMC) of 50 universities and institutes and more than 150 scientists, including the University of Bristol, University of Exeter Medical School, King’s College London and Leiden University Medical Center, is published in Nature Genetics.

The analysis focused on the natural differences between individuals in their DNAm levels across the genome. DNAm plays a central role in gene regulation. It helps to define how cells respond to environmental signals and, ultimately, contributes to health or susceptibility to disease. However, the amount and the effects of differences in DNAm from one person to another is poorly understood. 

A powerful avenue into researching the biological consequences of changes in DNAm levels is to systematically compare DNA sequence variants to DNAm levels. GoDMC has completed the largest genetic study of DNAm to date by scanning for correlations between ten million genetic variants and 420,000 DNAm sites across the genome resulting in a database of >270,000 independent associations. This means that almost half of all DNAm sites in the genome are to some extent influenced by genetic factors. 

The international consortium analysed 32,851 participants collected from 38 studies across the world.  By providing a world-wide platform for collaboration and combining genetic and epidemiological expertise, the scientists of GoDMC has established a large resource of genetic effects on DNAm and how this atlas can be used to understand the genetic basis of DNAm variation. The atlas has already been used for a wide range of other research projects. 

The newly developed database has been used to search for instances of DNAm sites causally relating to 100 clinical characteristics and diseases. Vice versa, the study estimated the causal influences of these clinical characteristics and diseases on DNAm levels across the genome. These comparisons highlight that DNAm is unlikely to have a big role in causing disease but open the door to a range of further research. For example, this work suggests that understanding of DNAm variation between individuals and its influence on health and disease could be improved by studying other regulatory regions of the genome or other cell types.

Dr Josine Min, Research Fellow in Genetic and Epigenetic Epidemiology at the University of Bristol and GoDMC coordinator, said: “Understanding differences in genetic regulation between tissues that comprise diverse cell-types is complex. Our large-scale comparison of DNAm and genetics across blood, brain and adipose tissue highlighted that long distance regulation is largely shared across tissues but that localregulation is more tissue specific. Improved understanding of how different tissues develop and respond to disease will help to advance our understanding of the causes of disease.”

Dr Gibran Hemani, Associate Professor in Statistical Genetics at the University of Bristol, added: “A major objective of mapping genetic factors to DNAm is to help to determine how DNAm relates to diseases. By conducting such a large study, we had the opportunity to address this question with more power than previously. We were surprised to find that a causal relationship between DNAm and clinical characteristics and diseases was often not supported by our models. This really does present new challenges to us – are the models that we are using reflecting biology appropriately? Are the tissues that we are analysing the relevant ones? And are the assays that we use sufficiently precise?”

Caroline Relton, Professor of Epigenetic Epidemiology and MRC Investigator from the University of Bristol, who led GoDMC, said: “This study represents an enormous international effort to enhance our understanding of how our genomes are controlled and how they influence health and disease. The study is a testament to the importance of international collaboration. We expect that this atlas will be of use to the scientific community for a wide range of future research.”

Publication: Josine L. Min, et al., Genomic and phenotypic insights from an atlas of genetic effects on DNA methylation, Nature Genetics (2023). DOI: 10.1038/s41588-021-00923-x.

Original Story Source:  University of Bristol